These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32805151)

  • 1. Goal analysis in patients with limb spasticity treated with incobotulinumtoxinA in the TOWER study.
    Fheodoroff K; Scheschonka A; Wissel J
    Disabil Rehabil; 2022 Apr; 44(8):1367-1373. PubMed ID: 32805151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
    Nott MT; Barden HL; Baguley IJ
    J Rehabil Med; 2014 Oct; 46(9):864-8. PubMed ID: 25074437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.
    Eftekhar P; Mochizuki G; Dutta T; Richardson D; Brooks D
    Occup Ther Int; 2016 Dec; 23(4):379-389. PubMed ID: 27696580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the International Classification of Functioning, Disability and Health to support goal-setting practices in pediatric rehabilitation: a rapid review of the literature.
    Nguyen L; Cross A; Rosenbaum P; Gorter JW
    Disabil Rehabil; 2021 Mar; 43(6):884-894. PubMed ID: 31345067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L; Mesterman R; Gorter JW
    BMC Pediatr; 2018 Jan; 18(1):1. PubMed ID: 29301539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compiling standardized information from clinical practice: using content analysis and ICF Linking Rules in a goal-oriented youth rehabilitation program.
    Lustenberger NA; Prodinger B; Dorjbal D; Rubinelli S; Schmitt K; Scheel-Sailer A
    Disabil Rehabil; 2019 Mar; 41(5):613-621. PubMed ID: 28944699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of integrated upper limb spasticity management including repeat botulinum toxin type A (BoNT-A) injections on patient-centred goal attainment in real-life practice: results from the prospective, observational Upper Limb International Spasticity cohort study (ULIS-III) in a Russian subpopulation].
    Khat'kova SE; Baikova A; Maisonobe P; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(11):39-48. PubMed ID: 34932284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goals Set by Patients Using the
    Choi K; Peters J; Tri A; Chapman E; Sasaki A; Ismail F; Boulias C; Reid S; Phadke CP
    Physiother Can; 2017; 69(2):113-119. PubMed ID: 28539691
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA.
    Fheodoroff K; Rekand T; Medeiros L; Koßmehl P; Wissel J; Bensmail D; Scheschonka A; Flatau-Baqué B; Simon O; Dressler D; Simpson DM
    Health Qual Life Outcomes; 2020 Mar; 18(1):51. PubMed ID: 32131842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III).
    Turner-Stokes L; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Fheodoroff K
    BMJ Open; 2016 Jun; 6(6):e011157. PubMed ID: 27315835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Categorisation of goals set using Goal Attainment Scaling for treatment of leg spasticity: a multicentre analysis.
    Ashford S; Williams H; Nair A; Orridge S; Turner-Stokes L
    Disabil Rehabil; 2019 Aug; 41(16):1925-1930. PubMed ID: 29558228
    [No Abstract]   [Full Text] [Related]  

  • 13. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.
    Ashford S; Fheodoroff K; Jacinto J; Turner-Stokes L
    Clin Rehabil; 2016 Jun; 30(6):617-22. PubMed ID: 26141809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic stroke survivors with upper limb spasticity: linking experience to the ICF.
    Pike S; Lannin NA; Cameron L; Palit M; Cusick A
    Disabil Rehabil; 2022 Jul; 44(15):3925-3937. PubMed ID: 33725459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rehabilitation goals of people with spinal cord injuries can be classified against the International Classification of Functioning, Disability and Health Core Set for spinal cord injuries.
    Haas B; Playford ED; Ahmad AQ; Yildiran T; Gibbon AJ; Freeman JA
    Spinal Cord; 2016 Apr; 54(4):324-8. PubMed ID: 26345484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Jan; 53(1):jrm00133. PubMed ID: 33206198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICF-inspired goal-setting in developmental rehabilitation: an innovative framework for pediatric therapists.
    Angeli JM; Schwab SM; Huijs L; Sheehan A; Harpster K
    Physiother Theory Pract; 2021 Nov; 37(11):1167-1176. PubMed ID: 31766925
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.
    Wissel J; Bensmail D; Ferreira JJ; Molteni F; Satkunam L; Moraleda S; Rekand T; McGuire J; Scheschonka A; Flatau-Baqué B; Simon O; Rochford ET; Dressler D; Simpson DM;
    Neurology; 2017 Apr; 88(14):1321-1328. PubMed ID: 28283596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus.
    Bensmail D; Wissel J; Laffont I; Simon O; Scheschonka A; Flatau-Baqué B; Dressler D; Simpson DM
    Ann Phys Rehabil Med; 2021 Mar; 64(2):101376. PubMed ID: 32294561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a framework to define the functional goals and outcomes of botulinum toxin A spasticity treatment relevant to the child and family living with cerebral palsy using the International Classification of Functioning, Disability and Health for Children and Youth.
    Preston N; Clarke M; Bhakta B
    J Rehabil Med; 2011 Nov; 43(11):1010-5. PubMed ID: 22031347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.